@article{MAKHILLRJP20137312489,
    title = {Norstictic Acid Inhibits the Growth of Murine SV40 Transformed Lymphoid Carcinoma 
  Cells <I>In vitro</I>},
    journal = {Research Journal of Pharmacology},
    volume = {7},
    number = {3},
    pages = {26-28},
    year = {2013},
    issn = {1815-9362},
    doi = {rjpharm.2013.26.28},
    url = {https://makhillpublications.co/view-article.php?issn=1815-9362&doi=rjpharm.2013.26.28},
    author = {Bangolah,Shellaleh and},
    keywords = {Norstictic acid,cancer,growth,radiotherapy,in vitro,Buellia zahlbruckneri},
    abstract = {Researchers test the effects of Norstictic acid, secondary 
  metabolite of the lichen <I>Buellia zahlbruckneri</I>, on the growth of murine 
  SV40 transformed lymphoid carcinoma cells <I>in vitro</I>. Researchers find 
  that Norstictic acid is a potent inhibitor of growth. Researchers, also find 
  that Norstictic acid increases sensitivity of cells to radiation and this effect 
  is significant at a radiation intensity lower than the standard intensity of 
  cancer radiotherapy. On the basis of this study, Norstictic acid shows promise 
  for combined-modality cancer treatment.}
    }